| View |
|
DR-XY43854
|
Docetaxel
|
Doxestad
|
20mg/mL
|
Concentrate for Solution for Infusion
|
Antineoplastic
|
Actavis Italy S.p.A.
|
Italy
|
Initial (Variation)
|
13 September 2022
|
13 September 2027
|
| View |
|
DR-XY43857
|
Labetalol hydrochloride
|
Abetol
|
5 mg/mL (100 mg/20 mL)
|
Solution for Injection (IV)
|
Alpha and Beta Blocking Agent
|
Swiss Parenterals Ltd.
|
India
|
Renewal
|
25 July 2024
|
07 November 2029
|
| View |
|
DR-XY43859
|
Azithromycin (as Dihydrate)
|
Azik
|
500mg
|
Film-Coated Tablet
|
ANTIBACTERIAL (MACROLIDE)
|
Kusum Healthcare Private Limited
|
India
|
Automatic Renewal
|
21 September 2021
|
13 November 2026
|
| View |
|
DR-XY43861
|
Zoledronic Acid
|
Bomozid
|
4 mg
|
Lyophilized Powder for IV Infusion for injection
|
-
|
Atlanta Biologicals Pvt. Ltd.
|
India
|
-
|
13 February 2020
|
06 November 2024
|
| View |
DR-XY43863_PI_01.pdf
|
DR-XY43863
|
Tadalafil
|
Cialis
|
5 mg
|
Film-Coated Tablet
|
Phosphodiesterase Type-5 Inhibitor
|
Lilly del Caribe, Inc.
|
United States of America
|
Initial (from Monitored release)
|
06 June 2022
|
22 April 2026
|
| View |
DR-XY43865_PI_01.pdf
|
DR-XY43865
|
Indacaterol (as maleate) + Glycopyrronium (as bromide)
|
Ultibro Breezhaler
|
110 mcg/50 mcg
|
Powder for Inhalation in Hard Capsule
|
-
|
Siegfried Barbera, S.L.
|
Spain
|
Initial (Variation)
|
27 May 2022
|
27 May 2027
|
| View |
|
DR-XY43866
|
Vancomycin (As Hydrochloride)
|
Vancotech
|
500mg
|
Powder For Injection (Iv)
|
-
|
United Biotech (P) Limited
|
India
|
-
|
21 October 2019
|
06 November 2024
|
| View |
|
DR-XY43873
|
Atropine (as Sulfate)
|
Tropin
|
1mg/mL
|
Solution for Injection (IM/IV/SC)
|
-
|
Anhui Chengshi Manufacturer Medicine Co., Ltd.
|
China
|
-
|
19 December 2019
|
11 November 2024
|
| View |
|
DR-XY43874
|
Irbesartan
|
Irbemed
|
150 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
25 July 2024
|
11 November 2029
|
| View |
|
DR-XY43877
|
Levofloxacin (as Hydrochloride)
|
Levoxol
|
100mg/mL
|
Solution For Injection (Iv)
|
-
|
Cisen Pharmaceutical Co., Ltd
|
China
|
-
|
24 January 2020
|
17 November 2024
|
| View |
|
DR-XY43879
|
Iron + Cinchona pubescens Vahl (Red Cinchona Bark)
|
Serravallo'S Tonic
|
20mg, 7mg, per 30mL
|
Oral Solution
|
-
|
J. Serravallo S.n.C.
|
Italy
|
-
|
21 January 2020
|
17 November 2024
|
| View |
|
DR-XY43880
|
Fenofibrate
|
Lipirid
|
200 mg
|
Caspule
|
-
|
Pei Li Pharmaceutical Ind. Co., Ltd.
|
Taiwan
|
-
|
11 September 2019
|
17 November 2024
|
| View |
|
DR-XY43881
|
Oxymetazoline Hydrochloride
|
OXOZOLIN
|
500mcg/mL (0.05% w/v)
|
Nasal Solution
|
-
|
Aristopharma Ltd.
|
Bangladesh
|
-
|
13 November 2019
|
12 December 2024
|
| View |
|
DR-XY43882
|
Dopamine Hydrochloride
|
Dopagen
|
40mg/mL (200mg/5mL)
|
Solution for injection (IV)
|
-
|
Celogen Generics Pvt. Ltd.
|
India
|
-
|
27 August 2019
|
12 November 2024
|
| View |
|
DR-XY43884
|
Rosuvastattin (as calcium)
|
Turbovas -20
|
20 mg
|
Film Coated Tablet
|
HMG-COA Reductase Inhibitor
|
Micro Labs. Ltd.
|
India
|
Monitored Release
|
03 February 2022
|
12 November 2024
|
| View |
|
DR-XY43889
|
Carvedilol
|
None
|
25 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
12 January 2021
|
14 November 2024
|
| View |
|
DR-XY43891
|
Dobutamine (as Hydrochloride)
|
Dobugen
|
50mg/mL (250mg/5mL)
|
Solution For Injection (Iv)
|
Adrenergic Agent
|
Celogen Pharma Pvt. Ltd.
|
India
|
Renewal
|
31 May 2024
|
18 November 2029
|
| View |
|
DR-XY43892
|
Mesalazine
|
Pentasa
|
1 g
|
Prolonged-Release Tablet
|
Bowel Anti-inflammatory
|
Ferring International Center S.A.
|
Switzerland
|
Renewal
|
16 June 2024
|
14 November 2029
|
| View |
|
DR-XY43893
|
Levocetirizine Dihydrochloride
|
Levohizt
|
2.5mg/5mL
|
Syrup
|
-
|
Replica Remedies Pvt. Ltd.
|
India
|
-
|
19 December 2019
|
13 November 2024
|
| View |
|
DR-XY43894
|
Teicoplanin
|
Teicotan 200
|
200 mg
|
Lyophilized Powder for Injection (IM/IV)
|
Antibacterial
|
Gufic Biosciences Ltd.
|
India
|
Initial
|
25 March 2022
|
13 November 2024
|